Send to

Choose Destination
J Am Coll Nutr. 1998 Feb;17(1):75-8.

Effects of captopril and enalapril on zinc metabolism in hypertensive patients.

Author information

Department of Internal Medicine A, Assaf Harofeh Medical Center, Zerifin, Israel.



To investigate the effect of chronic captopril and enalapril treatment on zinc metabolism in hypertensive patients by assessing zinc levels in serum, urine and monocytes.


Patients with newly diagnosed essential hypertension were randomly divided into two treatment groups: those treated with captopril only (n = 16) and those treated with enalapril only (n = 18). Ten healthy subjects served as controls. Prior to the start of treatment and again 6 months later, zinc was assessed in the serum, in urine collected over 24 hours, and in peripheral blood monocytes.


Significant enhancement of 24-hour urinary zinc excretion (micrograms/24 hour) after 6 months of treatment was observed only in the captopril-treated group (p < 0.01). However, intramonocytic zinc levels decreased significantly in both of the treated groups over the same period (p < 0.01 and P < 0.04 in the captopril- and enalapril-treated groups, respectively).


Treatment of hypertensive patients with captopril or enalapril may result in zinc deficiency.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center